Felodipine sustained-release tablets are used to treat hypertension and stable angina pectoris.
This report contains market size and forecasts of Felodipine Sustained-Release Tablet in global, including the following market information:
Global Felodipine Sustained-Release Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Felodipine Sustained-Release Tablet Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Felodipine Sustained-Release Tablet companies in 2021 (%)
The global Felodipine Sustained-Release Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
2.5mg Per Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Felodipine Sustained-Release Tablet include Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, Changzhou Siyao Pharmaceutical, Mylan and Sandoz, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Felodipine Sustained-Release Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Felodipine Sustained-Release Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Felodipine Sustained-Release Tablet Market Segment Percentages, by Type, 2021 (%)
2.5mg Per Tablet
5mg Per Tablet
Others
Global Felodipine Sustained-Release Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Felodipine Sustained-Release Tablet Market Segment Percentages, by Application, 2021 (%)
Treat High Blood Pressure
Relieve Angina
Others
Global Felodipine Sustained-Release Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Felodipine Sustained-Release Tablet Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Felodipine Sustained-Release Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Felodipine Sustained-Release Tablet revenues share in global market, 2021 (%)
Key companies Felodipine Sustained-Release Tablet sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Felodipine Sustained-Release Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz